Effect of berberrubine on interleukin-8 and monocyte chemotactic protein-1 expression in human retinal pigment epithelial cell line

被引:29
作者
Cui, Hu-Shan
Hayasaka, Seiji
Zhang, Xue-Yun
Hayasaka, Yoriko
Chi, Zai-Long
Zheng, Lian-Shun
机构
[1] Toyama Univ, Dept Ophthalmol, Toyama 9300194, Japan
[2] Toyama Univ, Dept Pathol, Toyama 930, Japan
关键词
ARPE-19; cells; berberrubine; interleukin; 1; beta; tumor necrosis factor alpha; 8; monocyte chemotactic protein 1;
D O I
10.1016/j.lfs.2006.05.004
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We examined the effects of berberrubine, a protoberberine alkaloid, on interleukin-8 (IL-8) and monocyte chemotactic protein-1 (MCP-1) expression in a human retinal pigment epithelial cell line (ARPE-19) stimulated with interleukin-1 beta (IL-1 beta) or tumor necrosis factor (x (TNF-alpha). ARPE-19 cells were cultured to confluence. Berberrubine and IL-1 beta or TNF-a were added to the medium. IL-8 and MCP-1 protein concentrations were measured using enzyme-linked immunosorbent assay. IL-8 and MCP-1 mRNA were measured by real time polymerase chain reaction. Nuclear factor kappa B (NF-kappa B) translocation was examined by immunofluorescent staining/microscopy. Berberrubine dose-dependently inhibited IL-8 and NICP- I protein levels in the media and mRNA expression of the cells stimulated with IL-1 beta or TNF-alpha. Immunofluorescent staining/microscopy of NF-kappa B in the nucleus of unstimulated cells was faint (51 14 arbitrary units). Fluorescein was dense (215 42 or 170 24 arbitrary units, respectively) 30 min after stimulation with IL-1 beta or TNF-alpha and was decreased to 62 18 or 47 16 arbitrary units, respectively, by berberrubine. Berberrubine dose-dependently inhibited IL-8 and MCP-1 expression and protein secretion induced by IL-1 beta or TNF-alpha. Possibly, the effect on chemotactic factors may be via suppression of NF-kappa B translocation. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:949 / 956
页数:8
相关论文
共 33 条
[1]   Monocyte chemotactic protein-1 in proliferative vitreoretinal disorders [J].
AbuElAsrar, AM ;
VanDamme, J ;
Put, W ;
Veckeneer, M ;
Dralands, L ;
Billiau, A ;
Missotten, L .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1997, 123 (05) :599-606
[2]   Role of interleukin 8 in the pathogenesis of proliferative vitreoretinopathy [J].
Aksunger, A ;
Or, M ;
Okur, H ;
Hasanreisoglu, B ;
Akbatur, H .
OPHTHALMOLOGICA, 1997, 211 (04) :223-225
[3]  
Capeans C, 1998, RETINA-J RET VIT DIS, V18, P546
[4]   Control of chemokine production at the blood-retina barrier [J].
Crane, IJ ;
Wallace, CA ;
Mckillop-Smith, S ;
Forrester, JV .
IMMUNOLOGY, 2000, 101 (03) :426-433
[5]   Effect of berberine on interleukin 8 and monocyte chemotactic protein 1 expression in a human retinal pigment epithelial cell line [J].
Cui, Hu-Shan ;
Hayasaka, Seiji ;
Zhang, Xue-Yun ;
Hayasaka, Yoriko ;
Chi, Zai-Long ;
Zheng, Lian-Shun .
OPHTHALMIC RESEARCH, 2006, 38 (03) :149-157
[6]   Conversion of berberine into berberrubine by selective demethylation under microwave irradiation [J].
Das, B ;
Srinivas, KVNS .
SYNTHETIC COMMUNICATIONS, 2002, 32 (19) :3027-3029
[7]   ARPE-19, a human retinal pigment epithelial cell line with differentiated properties [J].
Dunn, KC ;
AotakiKeen, AE ;
Putkey, FR ;
Hjelmeland, LM .
EXPERIMENTAL EYE RESEARCH, 1996, 62 (02) :155-169
[8]   Interferon-induced protein 10 and interleukin 8 - C-X-C chemokines present in proliferative diabetic retinopathy [J].
Elner, SG ;
Strieter, R ;
Bian, ZM ;
Kunkel, S ;
Mokhtarzaden, L ;
Johnson, M ;
Lukacs, N ;
Elner, VM .
ARCHIVES OF OPHTHALMOLOGY, 1998, 116 (12) :1597-1601
[9]  
ELNER SG, 1991, LAB INVEST, V64, P819
[10]   CYTOKINES IN PROLIFERATIVE DIABETIC-RETINOPATHY AND PROLIFERATIVE VITREORETINOPATHY [J].
ELNER, SG ;
ELNER, VM ;
JAFFE, GJ ;
STUART, A ;
KUNKEL, SL ;
STRIETER, RM .
CURRENT EYE RESEARCH, 1995, 14 (11) :1045-1053